Bicara Therapeutics Inc
Price
FilingsNewest: 8-K, Material agreementAug 25 →Insiders5 insiders bought $4.8M in 1 open-market buy. 4 insiders sold $11.6M, all 64 sales on a 10b5-1 plan.→HoldersRa 11.0%Siren 8.5%Vestal Point Capital 8.0%→Financing →PeersClosest companies: TYRA, TNGX, BCYC→
From the filings
Figures
- Net income
- −$185.4Mlast 12 months
- Operating cash flow
- −$116.2Mlast 12 months
- Cash and equivalents
- $96.6Mat the last balance sheet
- Shares outstanding
- 65.9M shareson issue